Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginEquity AverageFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on EquityReturn on SalesTimes Interest Earned

Medicale (MCLE) Debt to Equity (2020 - 2023)

Medicale (MCLE) has disclosed Debt to Equity for 4 consecutive years, with -$0.5 as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Debt to Equity rose 22.5% year-over-year to -$0.5, compared with a TTM value of -$0.5 through Sep 2023, up 22.5%, and an annual FY2023 reading of -$0.5, up 22.5% over the prior year.
  • Debt to Equity was -$0.5 for Q3 2023 at Medicale, up from -$0.65 in the prior quarter.
  • Across five years, Debt to Equity topped out at $1.37 in Q1 2021 and bottomed at -$2.78 in Q3 2021.
  • Average Debt to Equity over 4 years is -$0.59, with a median of -$0.58 recorded in 2022.
  • Peak annual rise in Debt to Equity hit 76.69% in 2022, while the deepest fall reached 150.39% in 2022.
  • Year by year, Debt to Equity stood at -$0.31 in 2020, then tumbled by 38.83% to -$0.43 in 2021, then tumbled by 50.95% to -$0.65 in 2022, then increased by 22.5% to -$0.5 in 2023.
  • Business Quant data shows Debt to Equity for MCLE at -$0.5 in Q3 2023, -$0.65 in Q3 2022, and -$0.7 in Q2 2022.